2. Search Result
Search Result
Results for "

EC 3.1.1.8

" in MedChemExpress (MCE) Product Catalog:

8

Inhibitors & Agonists

1

Biochemical Assay Reagents

1

Recombinant Proteins

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-P2798
    Cholinesterase

    EC 3.1.1.8; BCHE

    		 Endogenous Metabolite Others
    Cholinesterase infers to acetylcholinesterase (AChE) and butyryl cholinesterase (BChE). AChE and BChE catalyze the hydrolysis of 6-MAM to morphine .
    Cholinesterase
  • HY-U00092
    BAY-Y 3118

    		Bacterial Infection
    BAY-Y 3118 is a new chlorofluoroquinolone with antimicrobial activity.
    BAY-Y <em>3118</em>
  • HY-U00092B
    (R,R)-BAY-Y 3118

    		Bacterial Infection
    (R,R)-BAY-Y 3118 is the R-enantiomer of BAY-Y 3118. (R,R)-BAY-Y 3118 shows weak bactericidal activity .
    (R,R)-BAY-Y <em>3118</em>
  • HY-R00549
    hsa-miR-3118 mimic

    		MicroRNA Cancer
    hsa-miR-3118 mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
    hsa-miR-3118 mimic
    hsa-miR-3118 mimic
  • HY-RI00549
    hsa-miR-3118 inhibitor

    		MicroRNA
    hsa-miR-3118 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    hsa-miR-3118 inhibitor
    hsa-miR-3118 inhibitor
  • HY-R00549A
    hsa-miR-3118 agomir

    		MicroRNA
    hsa-miR-3118 agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
    hsa-miR-3118 agomir
    hsa-miR-3118 agomir
  • HY-RI00549A
    hsa-miR-3118 antagomir

    		MicroRNA
    hsa-miR-3118 antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
    hsa-miR-3118 antagomir
    hsa-miR-3118 antagomir
  • HY-N4115
    Syrosingopine
    3 Publications Verification

    Su 3118

    		 Monocarboxylate Transporter Cardiovascular Disease Cancer
    Syrosingopine (Su 3118) is an orally active lactate transporters (MCT1/MCT4) dual inhibitor, which can reduce glycolysis and induce synthetic lethality in cancer cells when combine with metformin. Syrosingopine shows anti-hypertensive activity by depleting peripheral stores of norepinephrine .
    Syrosingopine

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: